Navigation Links
HemoShear Relocates and Expands Operations to Historic Martha Jefferson Property in Charlottesville, Virginia

CHARLOTTESVILLE, Va., Jan. 22, 2013 /PRNewswire/ -- HemoShear LLC, a biotechnology research company and leading developer of human-relevant systems for drug development and discovery, today announced that it will expand and relocate its operations to downtown Charlottesville, Virginia.  The Company will initially lease 14,800 square feet of the Cardwell Building in the historic former Martha Jefferson Hospital, now owned by Octagon Partners.  The lease allows for expansion to additional floors, as HemoShear's business requires.


HemoShear has grown to more than 30 employees since launching operations in 2009.  The Company continues to expand its customer base, which includes most major biopharmaceutical companies, by deploying its human-relevant systems and scientific expertise to reduce new drug R&D costs and improve success rates of new drug candidates. In 2012, HemoShear received the Rocket Award from the Charlottesville Business Innovation Council for rapid commercialization of a new technology.  

The renovated Cardwell space will allow for continued growth as HemoShear increases the scope of its pharmaceutical customer partnerships and its technology development.  Nicole Hastings , Ph.D., Vice President of Operations, said, "The Cardwell Building has an ideal infrastructure. The new space allows us to design for improved workflow, optimal productivity and quality.  We are also excited to be located near all of the downtown Charlottesville activities and to contribute to the growth of the Charlottesville bioscience community."

Demolition for the new space is underway and HemoShear is actively planning for its move to the Cardwell Building in mid-2013.  Mark Mascotte of MFM Partners, LLC, represented the landlord in the lease transaction.  StellarOne Bank and the Commonwealth of Virginia provided financial assistance to HemoShear. Local contractor Vision Building & Design, LLC will perform the demolition, design and space outfit. 

About HemoShear LLC 
HemoShear creates human-relevant systems that accurately replicate the biology of organ systems and diseases for drug discovery and development. Working in strategic partnerships with pharmaceutical, biotechnology and medical device companies, HemoShear generates meaningful data to increase confidence in decision-making, reduce risk of costly failures and identify efficacious therapies.  HemoShear's science leads to new medicines and improves human health.  


Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HemoShear Adds Industry Veterans Mehmood Khan and Fred Brown to Board of Managers
2. HemoShear Unveils In Vitro Steatosis System at Annual Meeting of the Association for the Study of Liver Diseases
3. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
4. Sysmex America Relocates Corporate Headquarters
5. ImmusanT Relocates Offices to State-of-the-Art Innovation Facility
6. Ultragenyx Relocates Company Headquarters to Support Operational Expansion
7. AAIPharma Expands Laboratory Service Offerings and Capabilities in its Technology Center
8. Concentra Expands Medical Services within the Dallas-Fort Worth area
9. AssureRx Health Expands Management Team to Support Increasing Business Growth
10. Cumberland Emerging Technologies Expands Life Sciences Center
11. VWR International, LLC Expands European Portfolio With Acquisitions Of Labonord SAS And Switch BVBA
Post Your Comments:
(Date:12/1/2015)... , Dec. 01, 2015 ... the "Veterinary Equipment and Disposables Market by ... report to their offering. --> ... "Veterinary Equipment and Disposables Market by product, ... report to their offering. --> Research ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), ... commercialization of therapies for cardiovascular conditions via the inhalation ... business in Australia . InCarda is ... Australia in the first half ... and medical centers in Adelaide ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... The ... the important role that meat and poultry play in a healthy, balanced diet. ... nutrition quiz where visitors can check their “meat IQ,” a section offering straight ...
(Date:12/1/2015)... ... 01, 2015 , ... Integrated Rental Services (“Integrated Rental”), a ... LLC (“JII”). , With support from JII, Integrated Rental is poised for expansion ... centers, clinics, research labs and medical facilities across the United States. , General ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , one ... its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging Design ... announced that it has been selected as a 2015 U.S.A. Taste Champion in the ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... the 1980s we have seen vast improvements in scientific research and discoveries, leading ... strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric breast ... focus of numerous abstracts accepted for presentation here, at the 101st Annual Radiology ... highlight the use of Volpara Solutions’ quantitative breast imaging software tools for providing ...
Breaking Medicine News(10 mins):